{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:36:38Z","timestamp":1786534598721,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8127","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2026,8,13]]},"DOI":"10.1038\/s41586-026-10706-1","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:46:46Z","timestamp":1782920806000},"page":"516-524","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correcting congenital myasthenia-associated acetylcholine receptor defects"],"prefix":"10.1038","volume":"656","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9958-7115","authenticated-orcid":false,"given":"Huanhuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6652-1974","authenticated-orcid":false,"given":"Nuriya","family":"Mukhtasimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elfie S.","family":"Cavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5441-7958","authenticated-orcid":false,"given":"Xilin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6263-7902","authenticated-orcid":false,"given":"Jason K.","family":"Sello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0594-6052","authenticated-orcid":false,"given":"Steven M.","family":"Sine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4283-1147","authenticated-orcid":false,"given":"Ryan E.","family":"Hibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"10706_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","volume":"14","author":"AG Engel","year":"2015","unstructured":"Engel, A. G., Shen, X.-M., Selcen, D. & Sine, S. M. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 14, 420\u2013434 (2015).","journal-title":"Lancet Neurol."},{"key":"10706_CR2","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41586-024-07774-6","volume":"632","author":"H Li","year":"2024","unstructured":"Li, H., Teng, J. & Hibbs, R. E. Structural switch in acetylcholine receptors in developing muscle. Nature 632, 1174\u20131180 (2024).","journal-title":"Nature"},{"key":"10706_CR3","doi-asserted-by":"crossref","unstructured":"Ramdas, S., Beeson, D. & Dong, Y. Y. Congenital myasthenic syndromes: increasingly complex. Curr. Opin. Neurol. 37, 493\u2013501 (2024).","DOI":"10.1097\/WCO.0000000000001300"},{"key":"10706_CR4","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez Cruz, P. M., Palace, J. & Beeson, D. The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes. Int. J. Mol. Sci. 19, 1677 (2018).","DOI":"10.3390\/ijms19061677"},{"key":"10706_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1172\/JCI16997","volume":"111","author":"X-M Shen","year":"2003","unstructured":"Shen, X.-M. et al. Mutation causing severe myasthenia reveals functional asymmetry of AChR signature cystine loops in agonist binding and gating. J. Clin. Investig. 111, 497\u2013505 (2003).","journal-title":"J. Clin. Investig."},{"key":"10706_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1212\/WNL.0b013e31825b5bda","volume":"79","author":"X-M Shen","year":"2012","unstructured":"Shen, X.-M., Brengman, J. M., Edvardson, S., Sine, S. M. & Engel, A. G. Highly fatal fast-channel syndrome caused by AChR \u025b subunit mutation at the agonist binding site. Neurology 79, 449\u2013454 (2012).","journal-title":"Neurology"},{"key":"10706_CR7","doi-asserted-by":"crossref","unstructured":"Cetin, H., Beeson, D., Vincent, A. & Webster, R. The structure, function, and physiology of the fetal and adult acetylcholine receptor in muscle. Front. Mol. Neurosci. 13, 581097 (2020).","DOI":"10.3389\/fnmol.2020.581097"},{"key":"10706_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","volume":"4","author":"AG Engel","year":"2007","unstructured":"Engel, A. G. The therapy of congenital myasthenic syndromes. Neurotherapeutics 4, 252\u2013257 (2007).","journal-title":"Neurotherapeutics"},{"key":"10706_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrn1101","volume":"4","author":"AG Engel","year":"2003","unstructured":"Engel, A. G., Ohno, K. & Sine, S. M. Sleuthing molecular targets for neurological diseases at the neuromuscular junction. Nat. Rev. Neurosci. 4, 339\u2013352 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"10706_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/nyas.13538","volume":"1412","author":"M Lee","year":"2018","unstructured":"Lee, M., Beeson, D. & Palace, J. Therapeutic strategies for congenital myasthenic syndromes. Ann. N. Y. Acad. Sci. 1412, 129\u2013136 (2018).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10706_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1196\/annals.1254.015","volume":"998","author":"SM Sine","year":"2003","unstructured":"Sine, S. M. et al. Mechanistic diversity underlying fast channel congenital myasthenic syndromes. Ann. N. Y. Acad. Sci. 998, 128\u2013137 (2003).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10706_CR12","doi-asserted-by":"crossref","unstructured":"Rahman, M. M. & Fatema, K. Fast channel congenital myesthenic syndrome: reporting two cases with mutation of CHRNE gene and short review. J. Pediatric Neurosci. 17, 160\u2013163 (2022).","DOI":"10.4103\/jpn.JPN_124_21"},{"key":"10706_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1203\/00006450-201011001-00661","volume":"68","author":"A Mallappa","year":"2010","unstructured":"Mallappa, A., Tirupathi, S., Boyd, J., B\u2019Connor, O. & Illingworth, M. 661 Fast channel syndrome: presentation, diagnosis and management in an infant. Pediatr. Res. 68, 338\u2013338 (2010).","journal-title":"Pediatr. Res."},{"key":"10706_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.nmd.2011.08.002","volume":"22","author":"J Palace","year":"2012","unstructured":"Palace, J. et al. Clinical features in a series of fast channel congenital myasthenia syndrome. Neuromuscul. Disord. 22, 112\u2013117 (2012).","journal-title":"Neuromuscul. Disord."},{"key":"10706_CR15","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1136\/jnnp.54.12.1069","volume":"54","author":"J Palace","year":"1991","unstructured":"Palace, J., Wiles, C. M. & Newsom-Davis, J. 3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia. J. Neurol. Neurosurg. Psychiatry 54, 1069 (1991).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10706_CR16","doi-asserted-by":"publisher","first-page":"e1770","DOI":"10.1212\/WNL.0000000000006478","volume":"91","author":"JC Kao","year":"2018","unstructured":"Kao, J. C. et al. Congenital myasthenic syndromes in adult neurology clinic. Neurology 91, e1770\u2013e1777 (2018).","journal-title":"Neurology"},{"key":"10706_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ajmg.a.38418","volume":"176","author":"JJ Dowling","year":"2018","unstructured":"Dowling, J. J., D. Gonorazky, H., Cohn, R. D. & Campbell, C. Treating pediatric neuromuscular disorders: the future is now. Am. J. Med. Genet. Part A 176, 804\u2013841 (2018).","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10706_CR18","doi-asserted-by":"crossref","unstructured":"Li, A. et al. Structures of the human adult muscle-type nicotinic receptor in resting and desensitized states. Cell Rep. 44, 5115581 (2025).","DOI":"10.1016\/j.celrep.2025.115581"},{"key":"10706_CR19","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bcp.2007.07.011","volume":"74","author":"D Bertrand","year":"2007","unstructured":"Bertrand, D. & Gopalakrishnan, M. Allosteric modulation of nicotinic acetylcholine receptors. Biochem. Pharmacol. 74, 1155\u20131163 (2007).","journal-title":"Biochem. Pharmacol."},{"key":"10706_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ana.410110603","volume":"11","author":"AG Engel","year":"1982","unstructured":"Engel, A. G. et al. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann. Neurol. 11, 553\u2013569 (1982).","journal-title":"Ann. Neurol."},{"key":"10706_CR21","doi-asserted-by":"crossref","unstructured":"Fukudome, T., Ohno, K., Brengman, J. M. & Engel, A. G. Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. NeuroReport 9, 1907\u20131911 (1998).","DOI":"10.1097\/00001756-199806010-00044"},{"key":"10706_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1749-6632.1998.tb10928.x","volume":"841","author":"T Fukudome","year":"1998","unstructured":"Fukudome, T., Ohno, K., Brengman, J. M. & Engel, A. G. AChR channel blockade by quinidine sulfate reduces channel open duration in the slow-channel congenital myasthenic syndrome. Ann. N. Y. Acad. Sci. 841, 199\u2013202 (1998).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10706_CR23","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1212\/01.WNL.0000061483.11417.1B","volume":"60","author":"CM Harper","year":"2003","unstructured":"Harper, C. M., Fukodome, T. & Engel, A. G. Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology 60, 1710\u20131713 (2003).","journal-title":"Neurology"},{"key":"10706_CR24","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1073\/pnas.94.5.2041","volume":"94","author":"J Garc\u00eda-Colunga","year":"1997","unstructured":"Garc\u00eda-Colunga, J., Awad, J. N. & Miledi, R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine\u2009(Prozac). Proc. Natl Acad. Sci. USA 94, 2041\u20132044 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10706_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.nurt.2008.07.003","volume":"5","author":"U Schara","year":"2008","unstructured":"Schara, U. & Lochm\u00fcller, H. Therapeutic strategies in congenital myasthenic syndromes. Neurotherapeutics 5, 542\u2013547 (2008).","journal-title":"Neurotherapeutics"},{"key":"10706_CR26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00415-011-6204-9","volume":"259","author":"A Chaouch","year":"2012","unstructured":"Chaouch, A. et al. A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome. J. Neurol. 259, 474\u2013481 (2012).","journal-title":"J. Neurol."},{"key":"10706_CR27","doi-asserted-by":"publisher","first-page":"17660","DOI":"10.1073\/pnas.1414378111","volume":"111","author":"TK Nayak","year":"2014","unstructured":"Nayak, T. K. et al. Functional differences between neurotransmitter binding sites of muscle acetylcholine receptors. Proc. Natl Acad. Sci. USA 111, 17660\u201317665 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10706_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.neuron.2022.01.013","volume":"110","author":"E Zarkadas","year":"2022","unstructured":"Zarkadas, E. et al. Conformational transitions and ligand-binding to a muscle-type nicotinic acetylcholine receptor. Neuron 110, 1358\u20131370 (2022).","journal-title":"Neuron"},{"key":"10706_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neurol.2024.09.007","volume":"181","author":"MI Kediha","year":"2025","unstructured":"Kediha, M. I., Tazir, M., Sternberg, D., Eymard, B. & Ali Pacha, L. Congenital myasthenic syndromes by Epsilon subunit mutations: phenotypic profiles of 17 Algerian families. Rev. Neurol. 181, 79\u201384 (2025).","journal-title":"Rev. Neurol."},{"key":"10706_CR30","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1016\/j.cell.2025.03.004","volume":"188","author":"H Li","year":"2025","unstructured":"Li, H. et al. Autoimmune mechanisms elucidated through muscle acetylcholine receptor structures. Cell 188, 2390\u20132406 (2025).","journal-title":"Cell"},{"key":"10706_CR31","doi-asserted-by":"crossref","unstructured":"Beeson, D. & Newsom-Davis, J. in Channelopathies (eds Lehmann-Horn, F. & Jurkat-Rott, K.) 85\u2013114 (Elsevier Science, 2000).","DOI":"10.1016\/B978-044450489-0\/50006-9"},{"key":"10706_CR32","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/bph.13745","volume":"175","author":"J Wang","year":"2018","unstructured":"Wang, J. & Lindstrom, J. Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors. Br. J. Pharmacol. 175, 1805\u20131821 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"10706_CR33","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2024.01.032","volume":"187","author":"SM Burke","year":"2024","unstructured":"Burke, S. M. et al. Structural mechanisms of \u03b17 nicotinic receptor allosteric modulation and activation. Cell 187, 1160\u20131176 (2024).","journal-title":"Cell"},{"key":"10706_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2023.04.103","volume":"668","author":"A Saito","year":"2023","unstructured":"Saito, A., Matsui, S., Chino, A., Sato, S. & Takeshita, N. Discovery and pharmacological characterization of novel positive allosteric modulators acting on skeletal muscle-type nicotinic acetylcholine receptors. Biochem. Biophys. Res. Commun. 668, 27\u201334 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10706_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0896-6273(00)80289-5","volume":"17","author":"K Ohno","year":"1996","unstructured":"Ohno, K. et al. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor \u03b5 subunit. Neuron 17, 157\u2013170 (1996).","journal-title":"Neuron"},{"key":"10706_CR36","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/6326","volume":"2","author":"H-L Wang","year":"1999","unstructured":"Wang, H.-L. et al. Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat. Neurosci. 2, 226\u2013233 (1999).","journal-title":"Nat. Neurosci."},{"key":"10706_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1085\/jgp.20028568","volume":"120","author":"SM Sine","year":"2002","unstructured":"Sine, S. M. et al. Naturally occurring mutations at the acetylcholine receptor binding site independently alter ACh binding and channel gating. J. Gen. Physiol. 120, 483\u2013496 (2002).","journal-title":"J. Gen. Physiol."},{"key":"10706_CR38","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1172\/JCI63415","volume":"122","author":"X-M Shen","year":"2012","unstructured":"Shen, X.-M., Brengman, J. M., Sine, S. M. & Engel, A. G. Myasthenic syndrome AChR\u03b1 C-loop mutant disrupts initiation of channel gating. J. Clin. Investig. 122, 2613\u20132621 (2012).","journal-title":"J. Clin. Investig."},{"key":"10706_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jocn.2021.12.016","volume":"96","author":"C Dejthevaporn","year":"2022","unstructured":"Dejthevaporn, C. et al. Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine. J. Clin. Neurosci. 96, 85\u201389 (2022).","journal-title":"J. Clin. Neurosci."},{"key":"10706_CR40","doi-asserted-by":"crossref","unstructured":"Gisselmann, G., Alisch, D., Welbers-Joop, B. & Hatt, H. Effects of quinine, quinidine and chloroquine on human muscle nicotinic acetylcholine receptors. Front. Pharmacol. 9, 1339 (2018).","DOI":"10.3389\/fphar.2018.01339"},{"key":"10706_CR41","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1093\/hmg\/5.9.1217","volume":"5","author":"AG Engel","year":"1996","unstructured":"Engel, A. G. et al. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum. Mol. Genet. 5, 1217\u20131227 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"10706_CR42","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/humu.23043","volume":"37","author":"X-M Shen","year":"2016","unstructured":"Shen, X.-M. et al. Mutations causing slow-channel myasthenia reveal that a valine ring in the channel pore of muscle AChR is optimized for stabilizing channel gating. Hum. Mutat. 37, 1051\u20131059 (2016).","journal-title":"Hum. Mutat."},{"key":"10706_CR43","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.biocel.2010.01.007","volume":"42","author":"HR Arias","year":"2010","unstructured":"Arias, H. R., Feuerbach, D., Bhumireddy, P. & Ortells, M. O. Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors. Int. J. Biochem. Cell Biol. 42, 712\u2013724 (2010).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10706_CR44","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.biocel.2006.01.006","volume":"38","author":"HR Arias","year":"2006","unstructured":"Arias, H. R., Bhumireddy, P. & Bouzat, C. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors. Int. J. Biochem. Cell Biol. 38, 1254\u20131276 (2006).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10706_CR45","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/0002-8703(86)90010-4","volume":"111","author":"DM Roden","year":"1986","unstructured":"Roden, D. M., Woosley, R. L. & Primm, R. K. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am. Heart J. 111, 1088\u20131093 (1986).","journal-title":"Am. Heart J."},{"key":"10706_CR46","unstructured":"Whittington, C. J., Kendall, T. & Pilling, S. Are the SSRIs and atypical antidepressants safe and effective for children and adolescents? Curr. Opin. Psychiatry 18, 21\u201325 (2005)."},{"key":"10706_CR47","doi-asserted-by":"crossref","unstructured":"Montgomery, S., Ferguson, J. M. & Schwartz, G. E. The antidepressant efficacy of reboxetine in patients with severe depression. J. Clin. Psychopharmacol. 23, 45\u201350 (2003).","DOI":"10.1097\/00004714-200302000-00008"},{"key":"10706_CR48","doi-asserted-by":"crossref","unstructured":"Andreoli, V., Caillard, V., Deo, R. S., Rybakowski, J. K. & Versiani, M. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression. J. Clin. Psychopharmacol. 22, 393\u2013399 (2002).","DOI":"10.1097\/00004714-200208000-00010"},{"key":"10706_CR49","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.neuint.2013.07.009","volume":"63","author":"HR Arias","year":"2013","unstructured":"Arias, H. R., Ortells, M. O. & Feuerbach, D. (\u2212)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites. Neurochem. Int. 63, 423\u2013431 (2013).","journal-title":"Neurochem. Int."},{"key":"10706_CR50","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1073\/pnas.92.3.758","volume":"92","author":"K Ohno","year":"1995","unstructured":"Ohno, K. et al. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc. Natl Acad. Sci. USA 92, 758\u2013762 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10706_CR51","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1523\/JNEUROSCI.17-15-05651.1997","volume":"17","author":"M Milone","year":"1997","unstructured":"Milone, M. et al. Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor \u03b1 subunit. J. Neurosci. 17, 5651 (1997).","journal-title":"J. Neurosci."},{"key":"10706_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1085\/jgp.75.5.469","volume":"75","author":"TM Dwyer","year":"1980","unstructured":"Dwyer, T. M., Adams, D. J. & Hille, B. The permeability of the endplate channel to organic cations in frog muscle. J. Gen. Physiol. 75, 469\u2013492 (1980).","journal-title":"J. Gen. Physiol."},{"key":"10706_CR53","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1152\/physrev.00015.2011","volume":"92","author":"SM Sine","year":"2012","unstructured":"Sine, S. M. End-plate acetylcholine receptor: structure, mechanism, pharmacology, and disease. Physiol. Rev. 92, 1189\u20131234 (2012).","journal-title":"Physiol. Rev."},{"key":"10706_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3233\/JND-170257","volume":"4","author":"S Nicole","year":"2017","unstructured":"Nicole, S. et al. Congenital myasthenic syndromes or inherited disorders of neuromuscular transmission: recent discoveries and open questions. J. Neuromuscul. Dis. 4, 269\u2013284 (2017).","journal-title":"J. Neuromuscul. Dis."},{"key":"10706_CR55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00401-023-02603-y","volume":"146","author":"MC Pham","year":"2023","unstructured":"Pham, M. C. et al. Individual myasthenia gravis autoantibody clones can efficiently mediate multiple mechanisms of pathology. Acta Neuropathol. 146, 319\u2013336 (2023).","journal-title":"Acta Neuropathol."},{"key":"10706_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mus.23870","volume":"49","author":"C Deflorio","year":"2014","unstructured":"Deflorio, C., Catalano, M., Fucile, S., Limatola, C. & Grassi, F. Fluoxetine prevents acetylcholine-induced excitotoxicity blocking human endplate acetylcholine receptor. Muscle Nerve 49, 90\u201397 (2014).","journal-title":"Muscle Nerve"},{"key":"10706_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsad177","volume":"46","author":"S Zhou","year":"2023","unstructured":"Zhou, S. et al. Adverse effects of 21 antidepressants on sleep during acute-phase treatment in major depressive disorder: a systemic review and dose-effect network meta-analysis. Sleep 46, zsad177 (2023).","journal-title":"Sleep"},{"key":"10706_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1034\/j.1600-0447.2000.02606.x","volume":"101","author":"L Tanum","year":"2000","unstructured":"Tanum, L. Reboxetine: tolerability and safety profile in patients with major depression. Acta Psychiatr. Scand. 101, 37\u201340 (2000).","journal-title":"Acta Psychiatr. Scand."},{"key":"10706_CR59","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41594-022-00737-3","volume":"29","author":"MM Rahman","year":"2022","unstructured":"Rahman, M. M. et al. Structural mechanism of muscle nicotinic receptor desensitization and block by curare. Nat. Struct. Mol. Biol. 29, 386\u2013394 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10706_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46028-x","volume":"15","author":"MJ Thompson","year":"2024","unstructured":"Thompson, M. J., Mansoub Bekarkhanechi, F., Ananchenko, A., Nury, H. & Baenziger, J. E. A release of local subunit conformational heterogeneity underlies gating in a muscle nicotinic acetylcholine receptor. Nat. Commun. 15, 1803 (2024).","journal-title":"Nat. Commun."},{"key":"10706_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"10706_CR62","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"10706_CR63","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J. 478, 4169\u20134185 (2021).","journal-title":"Biochem. J."},{"key":"10706_CR64","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"10706_CR65","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10706_CR66","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10706_CR67","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. Sect. D"},{"key":"10706_CR68","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s42003-021-02399-1","volume":"4","author":"R Sanchez-Garcia","year":"2021","unstructured":"Sanchez-Garcia, R. et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Commun. Biol. 4, 874 (2021).","journal-title":"Commun. Biol."},{"key":"10706_CR69","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0263-7855(97)00009-X","volume":"14","author":"OS Smart","year":"1996","unstructured":"Smart, O. S., Neduvelil, J. G., Wang, X., Wallace, B. A. & Sansom, M. S. P. HOLE: a program for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph. 14, 354\u2013360 (1996).","journal-title":"J. Mol. Graph."},{"key":"10706_CR70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 (2021).","journal-title":"Protein Sci."},{"key":"10706_CR71","doi-asserted-by":"publisher","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","volume":"90","author":"WS Pear","year":"1993","unstructured":"Pear, W. S., Nolan, G. P., Scott, M. L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA 90, 8392\u20138396 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10706_CR72","doi-asserted-by":"publisher","first-page":"9436","DOI":"10.1073\/pnas.90.20.9436","volume":"90","author":"SM Sine","year":"1993","unstructured":"Sine, S. M. Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity. Proc. Natl Acad. Sci. USA 90, 9436\u20139440 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10706_CR73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1085\/jgp.201611584","volume":"148","author":"N Mukhtasimova","year":"2016","unstructured":"Mukhtasimova, N., daCosta, C. J. B. & Sine, S. M. Improved resolution of single channel dwell times reveals mechanisms of binding, priming, and gating in muscle AChR. J. Gen. Physiol. 148, 43\u201363 (2016).","journal-title":"J. Gen. Physiol."},{"key":"10706_CR74","doi-asserted-by":"crossref","unstructured":"Colquhoun, D. & Sigworth, F. J. in Single-Channel Recording (eds Sakmann, B. & Neher, E.) 191\u2013263 (Springer, 1983).","DOI":"10.1007\/978-1-4615-7858-1_11"},{"key":"10706_CR75","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0006-3495(87)83298-8","volume":"52","author":"FJ Sigworth","year":"1987","unstructured":"Sigworth, F. J. & Sine, S. M. Data transformations for improved display and fitting of single-channel dwell time histograms. Biophys. J. 52, 1047\u20131054 (1987).","journal-title":"Biophys. J."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10706-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:03:08Z","timestamp":1786532588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-10706-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":75,"journal-issue":{"issue":"8127","published-print":{"date-parts":[[2026,8,13]]}},"alternative-id":["10706"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-10706-1","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}